Literature DB >> 9407057

Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1.

Y Rouillé1, S Kantengwa, J C Irminger, P A Halban.   

Abstract

Proglucagon is processed differentially in pancreatic alpha-cells and intestinal endocrine L cells to release either glucagon or glucagon-like peptide-1-(7-36amide) (tGLP-1), two peptide hormones with opposing biological actions. Previous studies have demonstrated that the prohormone convertase PC2 is responsible for the processing of proglucagon to glucagon, and have suggested that the related endoprotease PC3 is involved in the formation of tGLP-1. To understand better the biosynthetic pathway of tGLP-1, proglucagon processing was studied in the mouse pituitary cell line AtT-20, a cell line that mimics the intestinal pathway of proglucagon processing and in the rat insulinoma cell line INS-1. In both of these cell lines, proglucagon was initially cleaved to glicentin and the major proglucagon fragment (MPGF) at the interdomain site Lys70-Arg71. In both cell lines, MPGF was cleaved successively at the monobasic site Arg77 and then at the dibasic site Arg109-Arg110, thus releasing tGLP-1, the cleavages being less extensive in INS-1 cells. Glicentin was completely processed to glucagon in INS-1 cells, but was partially converted to oxyntomodulin and very low levels of glucagon in AtT-20 cells in the face of generation of tGLP-1. Adenovirus-mediated co-expression of PC3 and proglucagon in GH4C1 cells (normally expressing no PC2 or PC3) resulted in the formation of tGLP-1, glicentin, and oxyntomodulin, but no glucagon. When expressed in alphaTC1-6 (transformed pancreatic alpha-cells) or in rat primary pancreatic alpha-cells in culture, PC3 converted MPGF to tGLP-1. Finally, GLP-1-(1-37) was cleaved to tGLP-1 in vitro by purified recombinant PC3. Taken together, these results indicate that PC3 has the same specificity as the convertase that is responsible for the processing of proglucagon to tGLP-1, glicentin and oxyntomodulin in the intestinal L cell, and it is concluded that this enzyme is thus able to act alone in this processing pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407057     DOI: 10.1074/jbc.272.52.32810

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus--an adaptive response to hyperglycaemia?

Authors:  A M K Hansen; T B Bödvarsdottir; D N E Nordestgaard; R S Heller; C F Gotfredsen; K Maedler; J J Fels; J J Holst; A E Karlsen
Journal:  Diabetologia       Date:  2011-02-25       Impact factor: 10.122

2.  Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.

Authors:  Helga Ellingsgaard; Irina Hauselmann; Beat Schuler; Abdella M Habib; Laurie L Baggio; Daniel T Meier; Elisabeth Eppler; Karim Bouzakri; Stephan Wueest; Yannick D Muller; Ann Maria Kruse Hansen; Manfred Reinecke; Daniel Konrad; Max Gassmann; Frank Reimann; Philippe A Halban; Jesper Gromada; Daniel J Drucker; Fiona M Gribble; Jan A Ehses; Marc Y Donath
Journal:  Nat Med       Date:  2011-10-30       Impact factor: 53.440

3.  Relative quantitation of neuropeptides over a thousand-fold concentration range.

Authors:  Xiaowen Hou; Fang Xie; Jonathan V Sweedler
Journal:  J Am Soc Mass Spectrom       Date:  2012-09-20       Impact factor: 3.109

4.  Resistant maltodextrin or fructooligosaccharides promotes GLP-1 production in male rats fed a high-fat and high-sucrose diet, and partially reduces energy intake and adiposity.

Authors:  Tohru Hira; Ryoya Suto; Yuka Kishimoto; Sumiko Kanahori; Hiroshi Hara
Journal:  Eur J Nutr       Date:  2017-02-04       Impact factor: 5.614

5.  Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cord.

Authors:  Lydia K Miller; Xiaowen Hou; Ramona M Rodriguiz; Khatuna Gagnidze; Jonathan V Sweedler; William C Wetsel; Lakshmi A Devi
Journal:  J Neurochem       Date:  2011-11-01       Impact factor: 5.372

6.  Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet.

Authors:  M Sörhede Winzell; C L Brand; N Wierup; U G Sidelmann; F Sundler; E Nishimura; B Ahrén
Journal:  Diabetologia       Date:  2007-05-04       Impact factor: 10.122

7.  Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects.

Authors:  Xiaorong Zhu; An Zhou; Arunangsu Dey; Christina Norrbom; Raymond Carroll; Chunling Zhang; Virginie Laurent; Iris Lindberg; Randi Ugleholdt; Jens J Holst; Donald F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

8.  Variation at the DPP4 locus influences apolipoprotein B levels in South Asians and exhibits heterogeneity in Europeans related to BMI.

Authors:  Swneke D Bailey; Changchun Xie; Guillaume Paré; Alexandre Montpetit; Viswanathan Mohan; Salim Yusuf; Hertzel Gerstein; James C Engert; Sonia S Anand
Journal:  Diabetologia       Date:  2013-12-21       Impact factor: 10.122

9.  Transplantation of PC1/3-Expressing alpha-cells improves glucose handling and cold tolerance in leptin-resistant mice.

Authors:  Rhonda D Wideman; Sarah L Gray; Scott D Covey; Gene C Webb; Timothy J Kieffer
Journal:  Mol Ther       Date:  2008-10-21       Impact factor: 11.454

Review 10.  PCSK1 Variants and Human Obesity.

Authors:  B Ramos-Molina; M G Martin; I Lindberg
Journal:  Prog Mol Biol Transl Sci       Date:  2016-01-29       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.